This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Francis Ring
Associate Director, Manufacturing & Operations at Ionis Pharmaceuticals


Francis Ring is currently an Associate Director of Manufacturing & Operations at Ionis Pharmaceuticals in Carlsbad, California. At Ionis, Francis leads the design and implementation of automated equipment, including oligonucleotide synthesizers, custom ultrafiltration and chromatography skids, and the building automation. Francis has served as the Ionis engineering lead for multiple facility expansions, including Ionis’s new manufacturing building, and regularly consults with Ionis partners on facility and process design topics around the world. Prior to his 15 years at Ionis, Francis earned his B.S. in Chemical Engineering from Stanford University.

Agenda Sessions

  • Large-Scale Safety Considerations and Implementation of a Desensitized Explosive Reagent in Oligonucleotide Synthesis